Name | RKI-1447 |
Synonyms | CS-855 RKI1447 RKI-1447 RKI1447 RKI 1447 1-(3-HYDROXYBENZYL)-3-(4-(PYRIDIN-4-YL)THIAZOL-2-YL)UREA Urea, N-[(3-hydroxyphenyl)methyl]-N'-[4-(4-pyridinyl)-2-thiazolyl]- 1-(3-Hydroxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea RKI 1447 |
CAS | 1342278-01-6 |
EINECS | 200-256-5 |
Molecular Formula | C16H14N4O2S |
Molar Mass | 326.37 |
Density | 1.408±0.06 g/cm3(Predicted) |
Melting Point | >205oC (dec.) |
Solubility | 25°C: DMSO 65 mg/mL; Water <1 mg/mL; EtOH <1 mg/mL |
Appearance | Solid |
Color | Pale Yellow to Pale Beige |
pKa | 6.36±0.70(Predicted) |
Storage Condition | -20°C Freezer |
MDL | MFCD26142658 |
Use | RKI-1447 is an effective ROCK1 and ROCK2 inhibitor with IC50 of 14.5 nM and 6.2 nM respectively, and has anti-invasion and anti-tumor activities. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.064 ml | 15.32 ml | 30.64 ml |
5 mM | 0.613 ml | 3.064 ml | 6.128 ml |
10 mM | 0.306 ml | 1.532 ml | 3.064 ml |
5 mM | 0.061 ml | 0.306 ml | 0.613 ml |